Utilize este identificador para referenciar este registo:
http://hdl.handle.net/10451/40136| Título: | Predictors of ACEI/ARB therapy in patients with hypertrophic cardiomyopathy : results of a national registry |
| Autor: | Martins, E. Lebreiro, A. Sousa, C. Leite, S. Sousa, A. Belo, A. Brito, Dulce Cardim, N. |
| Palavras-chave: | Angiotensin-converting enzyme inhibitors Hypertrophic cardiomyopathy |
| Data: | 2018 |
| Editora: | Oxford University Press |
| Citação: | European Heart Journal, Volume 39, Issue suppl_1, August 2018, ehy563.P3544 |
| Resumo: | Introduction: Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) are not considered disease-modifying drugs in hypertrophic cardiomyopathy (HCM) and their use is usually dependent on other clinical indications. Few data exist about the use of ACEI/ARB in HC in the real world, particularly in patients with intraventricular obstruction. Objective: In this study, we sought to determine the frequency of ACEI / ARB therapy in patients with HCM and the predictors for their use. |
| Descrição: | © The European Society of Cardiology 2018. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org |
| Peer review: | yes |
| URI: | http://hdl.handle.net/10451/40136 |
| DOI: | 10.1093/eurheartj/ehy563.P3544 |
| ISSN: | 0195-668X |
| Versão do Editor: | https://academic.oup.com/eurheartj |
| Aparece nas colecções: | FM-CCUL-Artigos em Revistas Internacionais |
Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.
